Deacetylation of the tumor suppressor protein PML regulates hydrogen peroxide-Induced cell death

Cell Death and Disease

Volumn 5, Issue 7, 2014, Pages

  Guan, D ^a   Lim, J H ^a   Peng, L ^b   Liu, Y ^a   Lam, M ^a   Seto, E ^b   Kao, H Y ^a  

^a CASE WESTERN RESERVE UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b H LEE MOFFITT CANCER CENTER AND RESEARCH INSTITUTE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

HYDROGEN PEROXIDE; LYSINE; PROMYELOCYTIC LEUKEMIA PROTEIN; SIRTUIN 1; SIRTUIN 5; SUMO 1 PROTEIN; NUCLEAR PROTEIN; PML PROTEIN, HUMAN; SIRT1 PROTEIN, HUMAN; SIRT5 PROTEIN, HUMAN; SIRTUIN; SUMO1 PROTEIN, HUMAN; TRANSCRIPTION FACTOR; TUMOR SUPPRESSOR PROTEIN;

ACETYLATION; ARTICLE; CATALYSIS; CELL DEATH; CELL PROLIFERATION; CELL SURVIVAL; CELL VIABILITY; CELLULAR DISTRIBUTION; CONJUGATION; CONTROLLED STUDY; DEACETYLATION; EMBRYO; FEMALE; GENE SILENCING; HELA CELL LINE; HUMAN; HUMAN CELL; IMMUNOFLUORESCENCE MICROSCOPY; NUCLEAR LOCALIZATION SIGNAL; PRIORITY JOURNAL; PROTEIN ANALYSIS; PROTEIN DEPLETION; PROTEIN EXPRESSION; PROTEIN LOCALIZATION; PROTEIN MODIFICATION; PROTEIN PHOSPHORYLATION; PROTEIN PROCESSING; PROTEIN PROTEIN INTERACTION; REGULATORY MECHANISM; SUMOYLATION; UBIQUITINATION; WESTERN BLOTTING; WILD TYPE; CHEMISTRY; ENZYMOLOGY; GENETICS; METABOLISM; PROMYELOCYTIC LEUKEMIA; PROTEIN MOTIF;

ACETYLATION; AMINO ACID MOTIFS; HELA CELLS; HUMANS; HYDROGEN PEROXIDE; LEUKEMIA, PROMYELOCYTIC, ACUTE; NUCLEAR PROTEINS; SIRTUIN 1; SIRTUINS; SUMO-1 PROTEIN; TRANSCRIPTION FACTORS; TUMOR SUPPRESSOR PROTEINS;

EID: 84905442969     PISSN: None     EISSN: 20414889     Source Type: Journal    
DOI: 10.1038/cddis.2014.185     Document Type: Article

References (55)

1. de The H, Lavau C, Marchio A, Chomienne C, Degos L, Dejean A. The PML-RAR alpha fusion mRNA generated by the t(15;17) translocation in acute promyelocytic leukemia encodes a functionally altered RAR. Cell 1991; 66: 675-684
2. Ascoli CA, Maul GG. Identification of a novel nuclear domain. J Cell Biol 1991; 112: 785-795
3. Gurrieri C, Capodieci P, Bernardi R, Scaglioni PP, Nafa K, Rush LJ et al. Loss of the tumor suppressor PML in human cancers of multiple histologic origins. J Natl Cancer Inst 2004; 96: 269-279
4. Mu ZM, Le XF, Vallian S, Glassman AB, Chang KS. Stable overexpression of PML alters regulation of cell cycle progression in HeLa cells. Carcinogenesis 1997; 18: 2063-2069
5. Wang ZG, Delva L, Gaboli M, Rivi R, Giorgio M, Cordon-Cardo C et al. Role of PML in cell growth and the retinoic acid pathway. Science 1998; 279: 1547-1551
6. Wang ZG, Ruggero D, Ronchetti S, Zhong S, Gaboli M, Rivi R et al. PML is essential for multiple apoptotic pathways. Nat Genet 1998; 20: 266-272
7. Cheng X, Kao HY. Post-Translational modifications of PML: Consequences and implications. Front Oncol 2012; 2: 210
8. Salomoni P, Pandolfi PP. The role of PML in tumor suppression. Cell 2002; 108: 165-170
9. Guan D, Factor D, Liu Y, Wang Z, Kao HY. The epigenetic regulator UHRF1 promotes ubiquitination-Mediated degradation of the tumor-Suppressor protein promyelocytic leukemia protein. Oncogene 2012; 32: 3819-3828
10. Lim JH, Liu Y, Reineke E, Kao HY. Mitogen-activated protein kinase extracellular signalregulated kinase 2 phosphorylates and promotes Pin1 protein-Dependent promyelocytic leukemia protein turnover. J Biol Chem 2011; 286: 44403-44411
11. Reineke EL, Lam M, Liu Q, Liu Y, Stanya KJ, Chang KS et al. Degradation of the tumor suppressor PML by Pin1 contributes to the cancer phenotype of breast cancer MDA-MB- 231 cells. Mol Cell Biol 2008; 28: 997-1006
12. Gao C, Ho CC, Reineke E, Lam M, Cheng X, Stanya KJ et al. Histone deacetylase 7 promotes PML sumoylation and is essential for PML nuclear body formation. Mol Cell Biol 2008; 28: 5658-5667
13. Campagna M, Herranz D, Garcia MA, Marcos-Villar L, Gonzalez-Santamaria J, Gallego P et al. SIRT1 stabilizes PML promoting its sumoylation. Cell Death Differ 2011; 18: 72-79
14. Miki T, Xu Z, Chen-Goodspeed M, Liu M, Van Oort-Jansen A, Rea MA et al. PML regulates PER2 nuclear localization and circadian function. EMBO J 2012; 31: 1427-1439
15. Yang XJ, Seto E. Lysine acetylation: Codified crosstalk with other posttranslational modifications. Mol Cell 2008; 31: 449-461
16. Choudhary C, Kumar C, Gnad F, Nielsen ML, Rehman M, Walther TC et al. Lysine acetylation targets protein complexes and co-Regulates major cellular functions. Science 2009; 325: 834-840
17. Saunders LR, Verdin E. Sirtuins: Critical regulators at the crossroads between cancer and aging. Oncogene 2007; 26: 5489-5504
18. Finkel T, Deng CX, Mostoslavsky R. Recent progress in the biology and physiology of sirtuins. Nature 2009; 460: 587-591
19. Guarente L, Franklin H. Epstein Lecture: Sirtuins, aging, and medicine. N Engl J Med 2011; 364: 2235-2244
20. Herranz D, Serrano M. SIRT1: Recent lessons from mouse models. Nat Rev Cancer 2010; 10: 819-823
21. Song NY, Surh YJ. Janus-Faced role of SIRT1 in tumorigenesis. Ann N Y Acad Sci 2012; 1271: 10-19
22. Deng CX. SIRT1, is it a tumor promoter or tumor suppressor? Int J Biol Sci 2009; 5: 147-152
23. Stunkel W, Peh BK, Tan YC, Nayagam VM, Wang X, Salto-Tellez M et al. Function of the SIRT1 protein deacetylase in cancer. Biotechnol J 2007; 2: 1360-1368
24. Byles V, Chmilewski LK, Wang J, Zhu L, Forman LW, Faller DV et al. Aberrant cytoplasm localization and protein stability of SIRT1 is regulated by PI3K/IGF-1R signaling in human cancer cells. Int J Biol Sci 2010; 6: 599-612
25. Lim JH, Lee YM, Chun YS, Chen J, Kim JE, Park JW. Sirtuin 1 modulates cellular responses to hypoxia by deacetylating hypoxia-Inducible factor 1alpha. Mol Cell 2010; 38: 864-878
26. Yeung F, Hoberg JE, Ramsey CS, Keller MD, Jones DR, Frye RA et al. Modulation of NF-KappaB-Dependent transcription and cell survival by the SIRT1 deacetylase. EMBO J 2004; 23: 2369-2380
27. Nie Y, Erion DM, Yuan Z, Dietrich M, Shulman GI, Horvath TL et al. STAT3 inhibition of gluconeogenesis is downregulated by SirT1. Nat Cell Biol 2009; 11: 492-500
28. Yuan Z, Zhang X, Sengupta N, Lane WS, Seto E. SIRT1 regulates the function of the Nijmegen breakage syndrome protein. Mol Cell 2007; 27: 149-162
29. Rajamohan SB, Pillai VB, Gupta M, Sundaresan NR, Birukov KG, Samant S et al. SIRT1 promotes cell survival under stress by deacetylation-Dependent deactivation of poly(ADP-ribose) polymerase 1. Mol Cell Biol 2009; 29: 4116-4129
30. Ming M, Shea CR, Guo X, Li X, Soltani K, Han W et al. Regulation of global genome nucleotide excision repair by SIRT1 through xeroderma pigmentosum C. Proc Natl Acad Sci USA 2010; 107: 22623-22628
31. Sundaresan NR, Pillai VB, Wolfgeher D, Samant S, Vasudevan P, Parekh V et al. The deacetylase SIRT1 promotes membrane localization and activation of Akt and PDK1 during tumorigenesis and cardiac hypertrophy. Sci Signal 2011; 4: Ra46
32. Menssen A, Hydbring P, Kapelle K, Vervoorts J, Diebold J, Luscher B et al. The c-MYC oncoprotein, the NAMPT enzyme, the SIRT1-inhibitor DBC1, and the SIRT1 deacetylase form a positive feedback loop. Proc Natl Acad Sci USA 2012; 109: E187-E196
33. Wong S, Weber JD. Deacetylation of the retinoblastoma tumour suppressor protein by SIRT1. Biochem J 2007; 407: 451-460
34. Pickard A, Wong PP, McCance DJ. Acetylation of Rb by PCAF is required for nuclear localization and keratinocyte differentiation. J Cell Sci 2010; 123(Pt 21): 3718-3726
35. Ikenoue T, Inoki K, Zhao B, Guan KL. PTEN acetylation modulates its interaction with PDZ domain. Cancer Res 2008; 68: 6908-6912
36. Nakagawa T, Lomb DJ, Haigis MC, Guarente L. SIRT5 deacetylates carbamoyl phosphate synthetase 1 and regulates the urea cycle. Cell 2009; 137: 560-570
37. Lai CC, Lin PM, Lin SF, Hsu CH, Lin HC, Hu ML et al. Altered expression of SIRT gene family in head and neck squamous cell carcinoma. Tumour Biol 2013; 34: 1847-1854
38. O'Hagan HM, Wang W, Sen S, Destefano Shields C, Lee SS, Zhang YW et al. Oxidative damage targets complexes containing DNA methyltransferases, SIRT1, and polycomb members to promoter CpG Islands. Cancer Cell 2011; 20: 606-619
39. Rhee SG. Cell signaling. H2O2, a necessary evil for cell signaling. Science 2006; 312: 1882-1883
40. Hayakawa F, Abe A, Kitabayashi I, Pandolfi PP, Naoe T. Acetylation of PML is involved in histone deacetylase inhibitor-Mediated apoptosis. J Biol Chem 2008; 283: 24420-24425
41. Ren Q, Gorovsky MA. Histone H2A.Z acetylation modulates an essential charge patch. Mol Cell 2001; 7: 1329-1335
42. Megee PC, Morgan BA, Mittman BA, Smith MM. Genetic analysis of histone H4: Essential role of lysines subject to reversible acetylation. Science 1990; 247: 841-845
43. Giorgi C, Ito K, Lin HK, Santangelo C, Wieckowski MR, Lebiedzinska M et al. PML regulates apoptosis at endoplasmic reticulum by modulating calcium release. Science 2010; 330: 1247-1251
44. Bellodi C, Kindle K, Bernassola F, Cossarizza A, Dinsdale D, Melino G et al. A cytoplasmic PML mutant inhibits p53 function. Cell Cycle 2006; 5: 2688-2692
45. Bellodi C, Kindle K, Bernassola F, Dinsdale D, Cossarizza A, Melino G et al. Cytoplasmic function of mutant promyelocytic leukemia (PML) and PML-retinoic acid receptor-alpha. J Biol Chem 2006; 281: 14465-14473
46. Gao YM, Zhong L, Zhang X, Hu XX, Liu BZ. PML(NLS(-)) inhibits cell apoptosis and promotes proliferation in HL-60 cells. Int J Med Sci 2013; 10: 498-507
47. Le XF, Yang P, Chang KS. Analysis of the growth and transformation suppressor domains of promyelocytic leukemia gene, PML. J Biol Chem 1996; 271: 130-135
48. Li T, Diner BA, Chen J, Cristea IM. Acetylation modulates cellular distribution and DNA sensing ability of interferon-Inducible protein IFI16. Proc Natl Acad Sci USA 2012; 109: 10558-10563
49. de la Vega L, Grishina I, Moreno R, Kruger M, Braun T, Schmitz ML. A redox-Regulated SUMO/acetylation switch of HIPK2 controls the survival threshold to oxidative stress. Mol Cell 2012; 46: 472-483
50. Nathan D, Ingvarsdottir K, Sterner DE, Bylebyl GR, Dokmanovic M, Dorsey JA et al. Histone sumoylation is a negative regulator in Saccharomyces cerevisiae and shows dynamic interplay with positive-acting histone modifications. Genes Dev 2006; 20: 966-976
51. Kotaja N, Karvonen U, Janne OA, Palvimo JJ. The nuclear receptor interaction domain of GRIP1 is modulated by covalent attachment of SUMO-1. J Biol Chem 2002; 277: 30283-30288
52. Rardin MJ, He W, Nishida Y, Newman JC, Carrico C, Danielson SR et al. SIRT5 regulates the mitochondrial lysine succinylome and metabolic networks. Cell Metab 2013; 18: 920-933
53. Geng YQ, Li TT, Liu XY, Li ZH, Fu YC. SIRT1 and SIRT5 activity expression and behavioral responses to calorie restriction. J Cell Biochem 2011; 112: 3755-3761
54. Reineke EL, Liu Y, Kao HY. Promyelocytic leukemia protein controls cell migration in response to hydrogen peroxide and insulin-Like growth factor-1. J Biol Chem 2010; 285: 9485-9492
55. Peng L, Ling H, Yuan Z, Fang B, Bloom G, Fukasawa K et al. SIRT1 negatively regulates the activities, functions, and protein levels of hMOF and TIP60. Mol Cell Biol 2012; 32: 2823-2836